Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 6, 2002, Pages 699-704

  Obana, Nobuya ^a   Takahashi, S ^a   Kinouchi, Y ^a   Negoro, K ^a   Takagi, S ^a   Hiwatashi, N ^a   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD14 gene; Inflammatory bowel disease; Single nucleotide polymorphism

Indexed keywords

CD14 ANTIGEN; DNA; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL GENETIC DISORDER; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS; AGED; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIGENS, CD14; BASE SEQUENCE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COMPARATIVE STUDY; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); PROBABILITY; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0035990180     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520212504     Document Type: Article

References (51)

1. Susceptibility genes in inflammatory bowel diseases
2. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking
3. Genetics of inflammatory bowel disease
4. Generics of inflammatory bowel disease
5. Familial occurrence of inflammatory bowel disease
6. Prevalence and family risk of ulcerative colitis and Crohn's disease: An epidemiological study among Europeans and south Asians in Leicestershire
7. The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives
8. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
9. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
10. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
11. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1
12. Linkage and association between inflammatory bowel disease and a locus on chromosome 12
13. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis
14. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple nonparametric analyses
15. A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort
16. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors
17. Genome-wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
18. A genome-wide search identifies potential new susceptibility loci for Crohn's disease
19. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
20. Lipoteichooic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway
21. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages
22. Monocyte antigen CD14 is a phospholipid anchored membrane protein
23. Endotoxin-neutralizing capacity of soluble CD14
24. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages
25. LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14
26. Toll, a new piece in the puzzle of innate immunity
27. The Toll-receptor family and control of innate immunity
28. Lipopolysaccharide induces rapid tyrosine phosphorylation of the mitogen-activated protein kinase erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14
29. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
30. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture
31. + population of monocytes in inflammatory bowel disease mucosa: Implications for pathogenesis
32. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells
33. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease
34. Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes
35. The role of bacterial flora in experimental models of intestinal inflammation
36. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level
37. Variable airway responsiveness to inhaled lipopolysaccharide
38. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
39. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
40. Intensive intravenous regimen for severe attacks of ulcerative colitis
41. Spl is a critical factor for the monocytic specific expression of human CD14
42. A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
43. Cytokines and inflammatory bowel disease
44. The role of interleukin-12 in inflammatory bowel disease
45. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice
46. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors
47. Colonic epithelial cell lines as a source of interleukin-8: Stimulation by inflammatory cytokines and bacterial lipopolysaccharide
48. Cell surface pbenotype and ultramicroscopic analysis of purified human enterocytes: A possible antigen-presenting cell in the intestine
49. Human CD14 mediates recognition and phagocytosis of apoptotic cells
50. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy